FCA
CCXI

FinTrust Capital Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

FinTrust Capital Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$3K – 1346
2022
Q1 		$3K Hold
100
– – ﹤0.01% 1133
2021
Q4 		$4K Buy
+100
New +$3.51K ﹤0.01% 1064

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

FinTrust Capital Advisors's CCXI Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 100 shares — an estimated $3K sold.

FinTrust Capital Advisors first reported a position in CCXI in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q4 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

  • FinTrust Capital Advisors reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 100 ChemoCentryx, Inc. shares in Q2 2022, an estimated $3K.
  • FinTrust Capital Advisors first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 2 quarters.
  • FinTrust Capital Advisors's ChemoCentryx, Inc. position peaked at $4K in Q4 2021.
  • 182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.